Spero Therapeutics
SPRO
#10353
Rank
C$61.99 M
Marketcap
C$1.06
Share price
-10.20%
Change (1 day)
-68.27%
Change (1 year)

Earnings for Spero Therapeutics (SPRO)

Earnings in 2026 (TTM): C$8.22 Million

According to Spero Therapeutics's latest financial reports the company's current earnings are C$42.96 Million. In 2025 the company made an earning of C$10.26 Million, an increase over its 2024 earnings that were of -C$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Spero Therapeutics from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$8.22 M-19.89%
2025 C$10.26 M-109.88%
2024 -C$0.11 Billion-360.42%
2023 C$39.91 M-163.53%
2022 -C$62.83 Million-50.14%
2021 -C$0.13 Billion11.06%
2020 -C$0.12 Billion25.15%
2019 -C$90.66 Million47.68%
2018 -C$61.39 Million5.61%
2017 -C$58.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
IBM
IBM
C$15.06 B 158,792.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Thomson Reuters
TRI
C$2.83 B 29,800.18%๐Ÿ‡จ๐Ÿ‡ฆ Canada
Franklin Covey
FC
C$9.21 M-2.80%๐Ÿ‡บ๐Ÿ‡ธ USA